Tobira Therapeutics Inc.
Division of Allergan PLC
www.tobiratherapeutics.com
Latest From Tobira Therapeutics Inc.
Genfit Thinks Intercept’s Lead In NASH Not As Wide As Perceived
Genfit believes elafibranor’s clean tolerability and safety profile may help narrow the gap between it and Intercept’s OCA, with safety questions delaying OCA’s entry to market. Part two of Scrip’s interview with Genfit’s CEO and COO.
Allergan's Big Deal: A Buyout, Not A Split, Appeases Wary Investors
Allergan was expected to announce soon that it would follow its shareholders' advice and split the company in two, but it's being acquired by AbbVie for $63bn instead, finally giving investors a big boost in their Allergan holdings after years of decline.
Conatus Accepts Defeat For Emricasan In NASH
After multiple Phase IIb trial failures, Conatus says it will fulfill contractual obligations and consider strategic alternatives. Partner Novartis was already focused on other candidates and partnerships in NASH.
Allergan Endures Another R&D Setback With Rapastinel Failing Three Pivotal Studies
Investor unrest expected as Allergan’s NMDA receptor modulator rapastinel fails in Phase III depression program, coming shortly after J&J’s approval in the class with Spravato.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Therapeutic Areas
- Hepatic (Liver)
- Infectious & Viral Diseases
- Inflammation
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Allergan PLC
- Senior Management
-
Laurent Fischer, MD, Chmn. & CEO
Christopher Peetz, CFO
Eric Lefebvre, MD, CMO
Helen Jenkins, COO
Pamela Vig, PhD, VP, Clinical Research & Discovery - Contact Info
-
Tobira Therapeutics Inc.
Phone: (650) 741-6625
701 Gateway Blvd.
Ste. 300
South San Francisco, CA 94080
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice